MR imaging features of primary sclerosing cholangitis: Patterns of cirrhosis in relationship to clinical severity of disease

Radiology

Volumn 226, Issue 3, 2003, Pages 675-685

  Bader, Till R ^a,b   Beavers, Kimberly L ^a   Semelka, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bile ducts, MR; Cholangitis; Liver, cirrhosis; Liver, MR

Indexed keywords

GADOLINIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHILD; CHOLANGITIS, SCLEROSING; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0037370033     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2263011623     Document Type: Article

References (48)

1. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332:924-932.
2. Sherlock S. Pathogenesis of sclerosing cholangitis: the role of nonimmune factors. Semin Liver Dis 1991; 11:5-10.
3. Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981; 1:632-640.
4. Angulo P, Larson DR, Therneau TM, LaRusso NF, Batts KP, Lindor KD. Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol 1999; 94:3310-3313.
5. LaRusso NF, Wiesner RH, Ludwig J, MacCaty RL. Current concepts: primary sclerosing cholangitis. N Engl J Med 1984; 310:899-903.
6. Porayko MK, LaRusso NF, Wiesner RH. Primary sclerosing cholangitis: a progressive disease? Semin Liver Dis 1991; 11:18-25.
7. Ernst O, Asselah T, Sergent G, et al. MR cholangiography in primary sclerosing cholangitis. AJR Am J Roentgenol 1998; 171:1027-1030.
8. Vitellas KM, Keogan MT, Freed KS, et al. Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. RadioGraphics 2000; 20:959-975.
9. Fulcher AS, Turner MA, Franklin KJ, et al. Primary sclerosing cholangitis: evaluation with MR cholangiography - a case-control study. Radiology 2000; 215:71-80.
10. Revelon G, Rashid A, Kawamoto S, Bluemke DA. Primary sclerosing cholangitis: MR imaging findings with pathologic correlation. AJR Am J Roentgenol 1999; 173:1037-1042.
11. Ito K, Mitchell DG, Outwater EK, Blasbalg R. Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol 1999; 172:1527-1533.
12. Dodd GD, Baron RL, Oliver JH, Federle MP. End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology 1999; 211:357-362.
13. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
14. Child CG, Turcotte J. Surgery and portal hypertension. In: Child CG, ed. The liver and portal hypertension. Philadelphia, Pa: Saunders, 1964; 50-52.
15. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
16. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
17. Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME. Computed tomography of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr 1986; 10:47-50.
18. Mitchell DG, Lovett KE, Hann HW, Ehrlich S, Palazzo J, Rubin R. Cirrhosis: multiobserver analysis of hepatic MR imaging findings in a heterogeneous population. J Magn Reson Imaging 1993; 3:313-321.
19. Van Beers B, Trigaux JP, Grandin C, et al. Regenerative nodules in hepatic cirrhosis: value of gradient-echo MR imaging with a surface coil. Acta Radiol 1992; 33:245-250.
20. Dodd GD, Baron RL, Oliver JH, Federle MP. Spectrum of imaging findings of the liver in end-stage cirrhosis. I. Gross morphology and diffuse abnormalities. AJR Am J Roentgenol 1999; 173:1031-1036.
21. Ito K, Mitchell DG. Hepatic morphologic changes in cirrhosis: MR imaging findings. Abdom Imaging 2000; 25:456-461.
22. Kita K, Kita M, Sato M, Ooshima A, Yamada R. MR imaging of liver cirrhosis. Acta Radiol 1996; 37:198-203.
23. Marti-Bonmati L, Talens A, del Olmo J, et al. Chronic hepatitis and cirrhosis: evaluation by means of MR imaging with histologic correlation. Radiology 1993; 188:37-43.
24. Dodd GD, Baron RL, Oliver JH, Federle MP. Spectrum of imaging findings of the liver in end-stage cirrhosis. II. Focal abnormalities. AJR Am J Roentgenol 1999; 173:1185-1192.
25. Krinsky GA, Lee VS. MR imaging of cirrhotic nodules. Abdom Imaging 2000; 25:471-482.
26. Okazaki H, Ito K, Fujita T, Koike S, Takano K, Matsunaga N. Discrimination of alcoholic from virus-induced cirrhosis on MR imaging. AJR Am J Roentgenol 2000; 175:1677-1681.
27. Krinsky GA, Lee VS, Theise ND. Focal lesions in the cirrhotic liver: high resolution ex vivo MRI with pathologic correlation. J Comput Assist Tomogr 2000; 24:189-196.
28. Murakami T, Kuroda C, Marukawa T, et al. Regenerating nodules in hepatic cirrhosis: MR findings with pathologic correlation. AJR Am J Roentgenol 1990; 155:1227-1231.
29. Ohtomo K, Itai Y, Ohtomo Y, Shiga J, Iio M. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation. AJR Am J Roentgenol 1990; 154:505-507.
30. Taylor AJ, Carmody TJ, Quiroz FA, et al. Focal masses in cirrhotic liver: CT and MR imaging features. AJR Am J Roentgenol 1994; 163:857-862.
31. Roncalli M, Roz E, Coggi G, et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 1999; 30:1174-1178.
32. Krinsky GA, Theise ND, Rofsky NM, Mizrachi H, Tepperman LW, Weinreb JC. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging - a case report. Radiology 1998; 209:461-464.
33. Kelekis NL, Semelka RC, Worawattanakul S, et al. Hepatocellular carcinoma in North America: a multlinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 1998; 170:1005-1013.
34. Harrison RF, Hubscher SG. The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis. Histopathology 1991; 19:321-327.
35. Ludwig J. Small-duct primary sclerosing cholangitis. Semin Liver Dis 1991; 11:11-17.
36. Ruf G, Mappes HJ, Lausen M, Schoffel U, Koch H, Farthmann EH. The pathomorphology of the liver after unilateral hepatic duct obstruction with laboratory chemical observations of the course in the dog. Helv Chir Acta 1989; 56:169-173.
37. Hadjis NS, Adam A, Blenkharn I, Hatzis G, Benjamin IS, Blumgart LH. Primary sclerosing cholangitis associated with liver atrophy. Am J Surg 1989; 158:43-47.
38. Ohtomo K, Baron RL, Dodd GD, Federle MP, Ohtomo Y, Confer SR. Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 1993; 189:871-874.
39. Kawai H, Aoyagi Y, Nomoto M, et al. Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis. Dig Dis Sci 2000; 45:680-684.
40. Bader TR, Braga L, Beavers KL, Semelka RC. MR imaging findings of infectious cholangitis. Magn Reson Imaging 2001; 19:781-788.
41. Kim MJ, Cha SW, Mitchell DG, Chung JJ, Park S, Chung JB. MR imaging findings in recurrent pyogenic cholangitis. AJR Am J Roentgenol 1999; 173:1545-1549.
42. Lebovics E, Palmer M, Woo J, Schaffner F. Outcome of primary sclerosing cholangitis: analysis of long-term observation of 38 patients. Arch Intern Med 1987; 147:729-731.
43. Ismail T, Angrisani L, Powell JE, et al. Primary sclerosing cholangitis: surgical options, prognostic variables and outcome. Br J Surg 1991; 78:564-567.
44. Angulo P, Larson DR, Therneau TM, LaRusso NF, Batts KP, Lindor KD. Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol 1999; 94:3310-3313.
45. Olsson R, Hagerstrand I, Broome U, et al. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol 1995; 48:933-935.
46. Scheuer PJ. Ludwig symposium on biliary disorders. II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clin Proc 1998; 73:179-183.
47. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3:628-637.
48. Gow PJ, Chapman RW. Liver transplantation for primary sclerosing cholangitis. Liver 2000; 20:97-103.